2.Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia.
Rong-Yu LV ; Fei-Qiu WEN ; Jie YU
Chinese Journal of Contemporary Pediatrics 2014;16(7):774-778
This article summarizes the pathogenesis of hypercoagulability in β thalassemia patients, including platelet activation, alteration of red blood cell membranes, abnormal expression of adhesion molecules on vascular endothelial cells and iron overload. Clinical evidence, clinical manifestations of hypercoagulable state and thrombosis in β thalassemia and the effect of splenectomy on hypercoagulable state were reviewed. Strategies to prevent and treat the thromboembolic events in β-thalassemia intermedia are also discussed, including transfusion therapy to raise hemoglobin levels, avoidance or delay of splenectomy and a number of treatments in the exploration.
Erythrocyte Aggregation
;
Humans
;
Thrombophilia
;
etiology
;
prevention & control
;
beta-Thalassemia
;
complications
3.Combined needlescopic cholecystectomy and laparoscopic splenectomy for the treatment of thalassaemic splenomegaly and cholelithiasis.
Jasmi AY ; Thambidorai CR ; Khairussalleh J
The Medical Journal of Malaysia 2003;58(3):443-445
Gallstone disease is a common association in patients with haematological splenomegaly. When indicated, simultaneous splenectomy and cholecystectomy should be performed and traditionally this is accomplished by open surgery. We report a 17 year old thalassaemic girl with splenomegaly complicated by gallstone pancreatitis. We treated her with a combination of needlescopic cholecystectomy and laparoscopic splenectomy as well as delivering the huge spleen via a pfannenstiel incision to hide the scar. We believe this technique is an acceptable alternative mainly for rapid delivery of the spleen and to minimize visible scars hence improving cosmesis.
Cholecystectomy, Laparoscopic/*methods
;
Cholelithiasis/etiology
;
Cholelithiasis/*surgery
;
Splenectomy/*methods
;
Splenomegaly/etiology
;
Splenomegaly/*surgery
;
beta-Thalassemia/*complications
4.CD4⁻ CD8⁻ TCRγδ⁺T cell large granular lymphocyte leukemia associated with β- thalassemia minor: one case report and literature review.
Yaping YU ; Ping SONG ; Jiangang MEI ; Zhiming AN ; Liping WANG ; Xiaogang ZHOU ; Feng LI ; Yumei TANG ; Yongping ZHAI
Chinese Journal of Hematology 2015;36(11):951-953
5.Comparision of Allogeneic Hematopoietic Stem Cell Transplantation between Children with Thalassemia of Different Ages.
Dong-Liang KANG ; Yong-Hong TAN ; Ya-Mei CHEN ; Jing-Yuan LU ; Jie SHI ; Xiu-Zhen YAN ; Quan-Yi LU
Journal of Experimental Hematology 2022;30(2):539-542
OBJECTIVE:
To investigate the difference of therapeutic effects on children with thalassemia at different age after hematopoietic stem cell transplantation.
METHODS:
The clinical data of children with thalassemia treated in our hospital were retrospectively analyzed. The children were divided into 2-5 years old group and 6-12 years old group. The success rate of implantation, transplant-related mortality, GVHD incidence, and other transplant-related complications, as well as thalassemia-free survival (TFS) were compared between the two groups.
RESULTS:
The incidence of GVHD, hemorrhagic cystitis and severe oral mucositis after transplantation in the 2-5 years old group were significantly lower than those in the 6-12 years old group, while there was no statistically significant difference in the TFS between the two groups.
CONCLUSION
Children in the low age (2-5 years old) group show fewer complications and higher quality of life after transplantation, therefore, stem cell transplantation at 2-5 years old is more conducive to rehabilitation of the children with thalassemia.
Child
;
Child, Preschool
;
Graft vs Host Disease/complications*
;
Hematopoietic Stem Cell Transplantation
;
Humans
;
Quality of Life
;
Retrospective Studies
;
Thalassemia/therapy*
;
beta-Thalassemia/therapy*
6.Molecular and prenatal diagnosis for a Chinese pregnant woman with a novel mutation of β thalassemia.
Ying HAO ; Zhi-yong XU ; Qing JIN ; Wei-qing WU ; Jun CAI ; Cai-qun LUO ; Jian-sheng XIE
Chinese Journal of Hematology 2011;32(4):245-248
OBJECTIVETo conduct molecular and prenatal diagnosis for a couple with β thalassemia.
METHODSBlood routine examination and hemoglobin analysis were used for screening of thalassemia. Seventeen common Chinese mutations of β thalassemia were detected for the carriers with β thalassemia using PCR/RDB. The unknown mutation of β thalassemia was identified by DNA sequencing and DHPLC analysis.
RESULTSThe husband was heterozygote of CD41/42 (-TCTT). The wife carried a mutation IVS-I-110 (G→A) of β thalassemia having not been reported in Chinese so far. The fetus was a double mutated heterozygote of IVS-I-110 (G→A) and CD41/42 (-TCTT). The pregnancy was terminated.
CONCLUSIONMutation IVS-I-110 (G→A) of β thalassemia in Chinese is of importance to the genetic counseling and prenatal diagnosis of thalassemia.
Base Sequence ; DNA Mutational Analysis ; Female ; Humans ; Male ; Mutation ; Pregnancy ; Pregnancy Complications, Hematologic ; genetics ; Prenatal Diagnosis ; beta-Thalassemia ; diagnosis ; genetics
7.A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis.
Qiang LI ; Li-Yan LI ; Qiu-Hua MO
Journal of Southern Medical University 2008;28(1):16-19
OBJECTIVETo analyze the relation between the genotype and phenotype in a Chinese patient with thalassemia intermedia and its implications for prenatal diagnosis and genetic counseling of thalassemia intermedia caused by co-existence of Hb H disease and beta; thalassemia major.
METHODSPhenotypic analysis was performed using standard hematological tests to measure red blood cell parameters and Hb concentration. Genotyping of beta thalassemia mutations and alpha thalassemia deletion were conducted using reverse dot-blot (RDB) assay and gap-PCR, respectively. We investigated the pathogenesis of this case by genotype-phenotype correlation analysis based on screening of the patient's family members. Prenatal diagnosis for a high-risk fetus in this family was performed by amniotic fluid DNA analysis.
RESULTSThe proband was identified as a patient with severe thalassemia intermedia caused by co-existence of Hb H disease (--(SEA)/-alpha (4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T), whose father was heterozygous for beta thalassemia (beta (CD17A)>T/beta (N)) and alpha-thalassemia trait (--(SEA)/) and the heterozygous for beta thalassemia (beta (IVS2-654C)>T / beta (N)) and silent alpha-thalassemia (-alpha (4.2)/). The result of prenatal diagnosis showed co-existence of beta thalassemia major and silent alpha thalassemia in the high-risk fetus, and the parents requested termination of pregnancy after genetic counseling.
CONCLUSIONWe report for the first time a rare thalassemia intermedia case resulting from 4 complex alpha/beta thalassemia combination and the molecular pathogenesis of thalassemia intermedia is updated in the Chinese population. The practice of prenatal diagnosis in this case may also provide reference for diagnosis of similar cases.
Adult ; Child, Preschool ; China ; Female ; Genotype ; Humans ; Male ; Nucleic Acid Hybridization ; methods ; Phenotype ; Polymerase Chain Reaction ; methods ; Pregnancy ; Prenatal Diagnosis ; methods ; alpha-Thalassemia ; complications ; diagnosis ; genetics ; beta-Thalassemia ; complications ; diagnosis ; genetics
8.High-dose cyclophosphamide for severe aplastic anemia associated with β-thalassemia: a case report and literatures review.
Xin ZHAO ; Yuan LI ; Kang ZHOU ; Li ZHANG ; Li-ping JING ; Lei YE ; Guang-xin PENG ; Yang LI ; Jian-ping LI ; Hui-hui FAN ; Lin SONG ; Feng-kui ZHANG
Chinese Journal of Hematology 2013;34(6):532-535
OBJECTIVETo investigate the clinical features and therapeutic method for severe aplastic anemia (SAA) associated with β-thalassemia, and to improve the recognition of the disease.
METHODSOne patient hospitalized for pancytopenia was reported and the related literatures were reviewed.
RESULTSA 14-years old girl who presented with anemia from her childhood was hospitalized for acute onset of pancytopenia. Routine blood test showed that WBC count was 1.28×10⁹/L, hemoglobin 65 g/L, platelet count 18×10⁹/L, reticulocyte count 2×10⁹/L, neutrophil count 0.03×10⁹/L and mean corpuscular volume 59.6 fl, respectively. Both bone marrow aspiration and biopsy showed hypoplasia. Her red blood cells presented as microcytic hypochromic and target erythrocytes were common on peripheral blood smear. DNA analysis of the patient and her mother showed exon 17 heterozygous β-thalassemia (c.52 A>T). A diagnosis of SAA associated with β-thalassemia was clarified and high-dose cyclophosphamide (HD-CTX, 1.2 g/d×4 d) plus cyclosporine were offeved, which eventually led to a complete hematologic remission 12 months later.
CONCLUSIONThis was the first report of SAA associated with β-thalassemia, and the regimen of HD-CTX led to a complete hematologic remission.
Adolescent ; Anemia, Aplastic ; complications ; drug therapy ; Cyclophosphamide ; administration & dosage ; therapeutic use ; Female ; Humans ; Immunosuppressive Agents ; administration & dosage ; therapeutic use ; beta-Thalassemia ; complications ; drug therapy
9.Relationship between growth disorders and iron overload in children with beta-thalassemia major.
Yong-Lan HUANG ; Sha LIU ; Ting XIA ; Wen-Ge HAO ; Wei LIANG ; Xin SUN
Chinese Journal of Contemporary Pediatrics 2008;10(5):603-606
OBJECTIVETo study the status of growth and development and the relationship between growth disorders and iron overload in children with beta-thalassemia major.
METHODSFifty children with beta-thalassemia major and who received blood transfusion therapy regularly (age: 9 months-17 years) were enrolled. They were subjected to a thorough history taking, clinical examinations, and laboratory examinations, including complete blood count, alanine transferasa (ALT) and serum ferritin. The physical growth parameters, such as height and weight, were compared with the reference values of Chinese children.
RESULTSTwenty-four patients (48%) were of short stature with height under the 3th percentile. Among them, 15 cases presented with their height and weight both under the 3th percentile. Spontaneous sex development was seen in 7 cases out of 21 over 10-year-old patients. No sex development was found in 4 out of 8 patients who were over 14 years old. The patients with a height under the 10th percentile (n=31) had higher serum ferritin levels (8239.2+/-5865.5 mg/L vs 5028.1+/-3885.7 mg/L; P<0.05) and lower hemoglobin levels (68.2+/-12.3 g/L vs 79.7+/-14.5 g/L; P<0.05) as well as hepatomegaly when compared with those patients with a height over the 10th percentile (n=19). Serum ferritin levels in 20 patients with a weight under the 10th percentile were significantly higher than those in 30 patients with a height over the 10th percentile (9165.5+/-6042.5 mg/L vs 5567.3+/-4447.3 mg/L; P<0.05).
CONCLUSIONSShort stature, low weight and sex development delay are common in children with beta-thalassemia major. This may be related to iron overload.
Adolescent ; Blood Transfusion ; Child, Preschool ; Female ; Growth Disorders ; etiology ; Humans ; Infant ; Iron Overload ; complications ; Male ; Sexual Maturation ; Young Adult ; beta-Thalassemia ; complications ; therapy
10.Intracranial Extramedullary Hematopoiesis in Beta-Thalassemia.
Bivek KARKI ; Xu YI-KAI ; Karuna TAMRAKAR ; Wu YUAN-KUI
Korean Journal of Radiology 2012;13(2):240-243
Extramedullary hematopoiesis (EMH) represents tumor-like proliferation of hemopoietic tissue which complicates chronic hemoglobinopathy. Intracranial EMH is an extremely rare occurrence. Magnetic resonance imaging (MRI) offers a precise diagnosis. It is essential to distinguish EMH from other extradural central nervous system tumors, because treatment and prognosis are totally different. Herein, we report the imaging findings of beta-thalassemia in a 13-year-old boy complaining of weakness of left side of the body and gait disturbance; CT and MRI revealed an extradural mass in the right temporoparietal region.
Adolescent
;
Brain Diseases/diagnosis/*etiology/surgery
;
Diagnosis, Differential
;
*Hematopoiesis, Extramedullary
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Tomography, X-Ray Computed
;
beta-Thalassemia/*complications